BofA analyst Kevin Fischbeck lowered the firm’s price target on Molina Healthcare (MOH) to $166 from $190 and keeps an Underperform rating on the shares. After commentary on the company’s call that the base 2025 EPS to use for forecasting future years is closer to $15, the firm is lowering its 2026 and 2027 adjusted EPS estimates to $18.50 and $23.00, respectively.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MOH: